The South African Health Products Regulatory Authority has approved the use of the Sinovac Covid-19 vaccine.
However, under certain conditions.
The approval is under Section 21 of the Medicines and Related Substance Act.
Individuals between the ages of 18 and 59 years can use the vaccine.
There are two doses that are administered 14 to 28 days apart.
One of the conditions is that Sinovac must submit the final results of ongoing clinical studies.
It also needs to submit periodic safety updates.
The Sinovac vaccine has a provisional shelf life of 24 months.
More Stories
Debt Ceiling Deal Wins House Approval
SA’s Health System A ‘Dysfunctional Mess’ That Can’t Be Fixed – Makgoba
Zimbabweans In SA Have A Month To Find Alternative Ways To Regularise Stay
Power Grid Collapse ‘Highly Improbable’ – Ramokgopa
Government Is Intensifying The Fight Against Crime – Ramaphosa
Ending Loadshedding Is Ramaphosa’s Top Priority
HEALA Urges SA Public To Comment On Draft Food Labelling Regulations
There’s Been An Improvement in Implementation Of Energy Action Plan – Ramokgopa
Waste To Energy: The Solution That Begs To Be Implemented
Stage 4 And 5 Blackouts Until Further Notice
Ramaphosa Appoints Panel To Probe Docking Of ‘Lady R’
Economists Predict Moderate Interest Rate Hike After Consumer Inflation Drop